Medpace Holdings, Inc. NMS · MEDP
Price alert —
Sign in to get a one-time email the moment MEDP crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · MEDP
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.7B | $0.1B | $0.1B | $0.1B | 17.5% | 20.0% |
| 2025-12-31 | $0.7B | $0.1B | $0.2B | $0.2B | 19.1% | 21.6% |
| 2025-09-30 | $0.7B | $0.1B | $0.1B | $0.2B | 16.8% | 21.5% |
| 2025-06-30 | $0.6B | $0.1B | $0.1B | $0.1B | 15.0% | 20.9% |
| 2025-03-31 | $0.6B | $0.1B | $0.1B | $0.1B | 20.5% | 20.3% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare MEDP vs peers
Line MEDP up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with MEDP
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-04-22 | 4.28 | 3.96 | +8.2% | -22.6% |
| 2026-02-09 | 4.67 | 4.23 | +10.5% | -15.9% |
| 2025-10-22 | 3.86 | 3.57 | +8.1% | +9.1% |
| 2025-07-21 | 3.10 | 3.00 | +3.5% | +54.7% |
| 2025-04-21 | 3.67 | 3.07 | +19.6% | -2.3% |
| 2025-02-10 | 3.68 | 3.12 | +18.1% | -7.5% |
| 2024-10-21 | 3.01 | 2.87 | +5.2% | -7.5% |
| 2024-07-22 | 2.76 | 2.63 | +5.2% | -18.3% |
| 2024-04-22 | 3.22 | 2.49 | +29.2% | +8.2% |
| 2024-02-12 | 2.48 | 2.52 | -1.8% | +12.3% |
| 2023-10-23 | 2.24 | 2.19 | +2.1% | +19.7% |
| 2023-07-24 | 1.95 | 2.00 | -2.4% | +3.9% |
| 2023-04-24 | 2.28 | 1.88 | +21.5% | +11.2% |
| 2023-02-13 | 2.14 | 1.87 | +14.3% | -5.1% |
| 2022-10-24 | 2.07 | 1.54 | +34.2% | +37.7% |
| 2022-07-25 | 1.48 | 1.39 | +7.2% | -6.2% |
| 2022-04-25 | 1.71 | 1.31 | +30.4% | -10.4% |
| 2022-02-14 | 1.36 | 1.29 | +4.8% | -20.3% |
| 2021-10-25 | 1.32 | 1.12 | +17.9% | +13.1% |
| 2021-07-26 | 1.09 | 1.03 | +5.9% | -5.7% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| MEDP ★ | $15B | 33.8 | 28.7 | 5.7 | 25.1 | 25.7 | 71.9% | 26.5% | 16.6% | 3.20% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 33.64%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 2,470,440 | 8.65% |
| AQR Capital Management, LLC | 1,353,837 | 4.74% |
| Vanguard Portfolio Management LLC | 1,121,689 | 3.93% |
| Vanguard Capital Management LLC | 1,011,071 | 3.54% |
| Geode Capital Management, LLC | 745,106 | 2.61% |
| State Street Corporation | 682,229 | 2.39% |
| Wasatch Advisors LP | 636,595 | 2.23% |
| Invesco Ltd. | 577,574 | 2.02% |
| Renaissance Technologies, LLC | 504,668 | 1.77% |
| BAILLIE GIFFORD & CO | 503,191 | 1.76% |
Insider activity · 90d
6 buys / 1 sells · ratio 6.0 · Finnhub
- McCarthy Cornelius P. III M 56
- McCarthy Cornelius P. III M 10,352
- Carley Brian T M 71
- Carley Brian T M 32,825
- Kraft Robert O. M 64
- Kraft Robert O. M 955
- EWALD STEPHEN P M 0
- EWALD STEPHEN P SELL 20,343 @ $450.00
- EWALD STEPHEN P M 36,692 @ $138.87
- Zander Dani S. BUY 1,110
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-02 | FORM 4 | view · |
| 4 | 2026-07-02 | FORM 4 | view · |
| 4 | 2026-07-02 | FORM 4 | view · |
| 8-K | 2026-06-04 | 8-K | view · |
| 4 | 2026-06-01 | FORM 4 | view · |
| 8-K | 2026-05-19 | 8-K | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-04-28 | FORM 4 | view · |
| 4 | 2026-04-28 | FORM 4 | view · |
| 4 | 2026-04-28 | FORM 4 | view · |
| 4 | 2026-04-28 | FORM 4 | view · |
| 10-Q | 2026-04-23 | 10-Q | view · |
| 8-K | 2026-04-22 | 8-K | view · |
| 4 | 2026-04-02 | FORM 4 | view · |
| 4 | 2026-04-02 | FORM 4 | view · |
| 4 | 2026-04-02 | FORM 4 | view · |
| DEF 14A | 2026-04-01 | DEF 14A | view · |
| 4 | 2026-03-19 | FORM 4 | view · |
| 4 | 2026-03-19 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 10-K | 2026-02-10 | 10-K | view · |
| 8-K | 2026-02-09 | 8-K | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2025-12-09 | FORM 4 | view · |
| 4 | 2025-12-04 | FORM 4 | view · |
| 4 | 2025-12-04 | FORM 4 | view · |
| 4 | 2025-12-03 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
| 4 | 2025-12-01 | FORM 4 | view · |
| 4 | 2025-11-26 | FORM 4 | view · |
| 4 | 2025-11-26 | FORM 4 | view · |
| 4 | 2025-11-25 | FORM 4 | view · |
| 4 | 2025-11-24 | FORM 4 | view · |
| 4 | 2025-11-20 | FORM 4 | view · |
| 4 | 2025-11-18 | FORM 4 | view · |
| 4 | 2025-11-18 | FORM 4 | view · |
| 4 | 2025-11-14 | FORM 4 | view · |
| 4 | 2025-11-12 | FORM 4 | view · |
| 4 | 2025-11-07 | FORM 4 | view · |
| 4 | 2025-11-03 | FORM 4 | view · |
| 4 | 2025-10-29 | FORM 4 | view · |
| 4 | 2025-10-29 | FORM 4 | view · |
| 4 | 2025-10-29 | FORM 4 | view · |
| 10-Q | 2025-10-23 | 10-Q | view · |
| 8-K | 2025-10-22 | 8-K | view · |
| 4 | 2025-10-02 | FORM 4 | view · |
| 4 | 2025-10-02 | FORM 4 | view · |
| 4 | 2025-10-02 | FORM 4 | view · |
| 4 | 2025-09-30 | FORM 4 | view · |
About MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Options picks · MEDP
ITM + OTM ideas from the latest scanLoading…
Congress trades · MEDP
STOCK Act disclosuresLoading…
SEC filings & insiders · MEDP
EDGAR · liveLoading…
Holders · MEDP
Institutions & insider activityLoading…